AI Summary
Enzymes are used to treat various diseases, but lack selectivity. Targeting enzymes to specific cells and tissues can reduce toxicity and provide new treatment options. This article reviews different targeted enzyme modalities and discusses the future of these approaches.
Enzymes are used to treat a wide variety of human diseases, including lysosomal storage disorders, clotting disorders, and cancers. While enzyme therapeutics catalyze highly specific reactions, they often suffer from a lack of cellular or tissue selectivity. Targeting an enzyme to specific disease-driving cells and tissues can mitigate off-target toxicities and provide novel therapeutic avenues to treat otherwise intractable diseases. Targeted enzymes have been used to treat cancer, in which the enzyme is either carefully selected or engineered to reduce on-target off-tumor toxicity, or to treat lysosomal storage disorders in cell-types that are not addressed by standard enzyme replacement therapies. In this review, we discuss the different targeted enzyme modalities and comment on the future of these approaches.
This article is Open Access
Please wait while we load your content… Something went wrong. Try again?